Claims for Patent: 9,422,364

✉ Email this page to a colleague

Summary for Patent: 9,422,364

Title:	Immunoglobulin preparation and storage system for an immunoglobulin preparation
Abstract:	The present invention relates to an immunoglobulin preparation comprising immunoglobulin in a mass-volume percentage of at least 4%, wherein the concentration of oxygen dissolved in the preparation at room temperature is less than 40 μmol/l.
Inventor(s):	Werner Maeder, Reinhard Franz Bolli, Peter Lerch, Renzo Pedrussio, Liane Hoefferer
Assignee:	CSL Behring AG
Application Number:	US13/581,245

Details for Patent 9,422,364

Glossary

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Csl Behring Ag	RHOPHYLAC	rho(d) immune globulin intravenous (human)	Injection	125070	February 12, 2004	9,422,364	2031-02-24
Csl Behring Ag	PRIVIGEN	immune globulin intravenous (human), 10% liquid	Injection	125201	July 26, 2007	9,422,364	2031-02-24
Csl Behring Ag	PRIVIGEN	immune globulin intravenous (human), 10% liquid	Injection	125201	October 02, 2009	9,422,364	2031-02-24
Csl Behring Ag	PRIVIGEN	immune globulin intravenous (human), 10% liquid	Injection	125201	February 07, 2013	9,422,364	2031-02-24
Csl Behring Ag	HIZENTRA	immune globulin subcutaneous (human), 20% liquid	Injection	125350	March 04, 2010	9,422,364	2031-02-24
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 9,422,364

Subscribe to access the full database, or Get Started Free
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2011104315	⤷ Get Started Free
United States of America	2023083398	⤷ Get Started Free
United States of America	2020054748	⤷ Get Started Free
United States of America	2017014509	⤷ Get Started Free
United States of America	2013017191	⤷ Get Started Free
United States of America	11419936	⤷ Get Started Free
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.